» Articles » PMID: 20818724

Historical Perspective on Mitochondrial Medicine

Overview
Date 2010 Sep 7
PMID 20818724
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

In this review, we trace the origins and follow the development of mitochondrial medicine from the premolecular era (1962-1988) based on clinical clues, muscle morphology, and biochemistry into the molecular era that started in 1988 and is still advancing at a brisk pace. We have tried to stress conceptual advances, such as endosymbiosis, uniparental inheritance, intergenomic signaling and its defects, and mitochondrial dynamics. We hope that this historical review also provides an update on mitochondrial medicine, although we fully realize that the speed of progress in this area makes any such endeavor akin to writing on water.

Citing Articles

Mitochondrial diseases: from molecular mechanisms to therapeutic advances.

Wen H, Deng H, Li B, Chen J, Zhu J, Zhang X Signal Transduct Target Ther. 2025; 10(1):9.

PMID: 39788934 PMC: 11724432. DOI: 10.1038/s41392-024-02044-3.


De Novo Mutation in a Patient with Encephalopathy, Cardiomyopathy and Fatal Non-Epileptic Paroxysmal Refractory Vomiting.

Berti B, Verrigni D, Nasca A, Di Nottia M, Leone D, Torraco A Int J Mol Sci. 2024; 25(14).

PMID: 39063023 PMC: 11277250. DOI: 10.3390/ijms25147782.


Mitochondrial Ataxias: Molecular Classification and Clinical Heterogeneity.

Lopriore P, Ricciarini V, Siciliano G, Mancuso M, Montano V Neurol Int. 2022; 14(2):337-356.

PMID: 35466209 PMC: 9036286. DOI: 10.3390/neurolint14020028.


Applying genomic and transcriptomic advances to mitochondrial medicine.

Macken W, Vandrovcova J, Hanna M, Pitceathly R Nat Rev Neurol. 2021; 17(4):215-230.

PMID: 33623159 DOI: 10.1038/s41582-021-00455-2.


The Dimensions of Primary Mitochondrial Disorders.

Schlieben L, Prokisch H Front Cell Dev Biol. 2020; 8:600079.

PMID: 33324649 PMC: 7726223. DOI: 10.3389/fcell.2020.600079.


References
1.
Haut S, Brivet M, Touati G, Rustin P, Lebon S, Garcia-Cazorla A . A deletion in the human QP-C gene causes a complex III deficiency resulting in hypoglycaemia and lactic acidosis. Hum Genet. 2003; 113(2):118-22. DOI: 10.1007/s00439-003-0946-0. View

2.
Moraes C, Shanske S, Tritschler H, Aprille J, Andreetta F, Bonilla E . mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet. 1991; 48(3):492-501. PMC: 1682992. View

3.
DiMauro S, Bonilla E, Lee C, SCHOTLAND D, Scarpa A, Conn Jr H . Luft's disease. Further biochemical and ultrastructural studies of skeletal muscle in the second case. J Neurol Sci. 1976; 27(2):217-32. DOI: 10.1016/0022-510x(76)90063-0. View

4.
Fernandez-Moreira D, Ugalde C, Smeets R, Rodenburg R, Lopez-Laso E, Ruiz-Falco M . X-linked NDUFA1 gene mutations associated with mitochondrial encephalomyopathy. Ann Neurol. 2007; 61(1):73-83. DOI: 10.1002/ana.21036. View

5.
Hakonen A, Isohanni P, Paetau A, Herva R, Suomalainen A, Lonnqvist T . Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain. 2007; 130(Pt 11):3032-40. DOI: 10.1093/brain/awm242. View